Background {#Sec1}
==========

The global burden of non-communicable diseases (NCDs) continues to increase. The World Health Organization projects that NCDs will account for 46% of mortality in sub-Saharan Africa (SSA) by 2030 \[[@CR1]\]. Currently, SSA has a dual burden of both infectious and non-infectious diseases. Chronic kidney disease (CKD) plays a major role as a cause and a consequence of other NCDs. A recent systematic review estimates the current prevalence of CKD in sub-Saharan Africa (SSA) at 13.9% (95% Confidence Interval \[CI\] 12.2--15.7) \[[@CR2]\]. It is also estimated that by 2030, 70% of worldwide end-stage renal disease (ESRD) will be in low income countries like those in SSA \[[@CR3]\]. In many countries the majority of CKD-related studies have focused on HIV-infected patients \[[@CR4]\]. In Uganda, a plurality of studies conducted in the recent past has focused on HIV-infected patients with little data available on non HIV-infected people \[[@CR5]--[@CR9]\]. This study involved participants with and without HIV in rural and semi-urban communities of Uganda.

There are many challenges concerning managing kidney diseases in SSA. First, we currently lack data on the major risk factors for chronic kidney disease in SSA due to lack of renal registries and meticulous longitudinal studies \[[@CR10], [@CR11]\]. The second challenge is that the majority of patients have no symptoms in the early stages of kidney disease and only present with advanced disease to health care facilities. In a recent study from a national referral hospital from Uganda, up to 51% (*n* = 111) of patients attending the outpatient nephrology care clinic had ESRD \[[@CR12]\]. This is largely because the risk factors that could trigger a high index of suspicion for kidney disease in most of SSA have not been well established \[[@CR11]\]. Once a patient develops end stage kidney disease there is need for renal replacement therapy irrespective of the primary cause. Early diagnosis and treatment on the other hand has been shown to delay or even reverse CKD but this is largely driven by screening for known risk factors and treating them \[[@CR13], [@CR14]\].

We determined the prevalence for CKD and associated factors in both rural and urban based community settings of Wakiso, Uganda using a cross-sectional design. We also compared the prevalence generated using the different glomerular estimation formulae including the Chronic Kidney Disease -Epidemiology Consortium equation (CKD-Epi), the Cockcroft Gault (CG) and the Modification of Diet in Renal Disease (MDRD) to establish a baseline differences between the formulae.

Methods {#Sec2}
=======

Between August 2012 and August 2013, MEPI-CVD (Medical Education Partnership Initiative on Cardiovascular Diseases) conducted a cross-sectional community based survey in an urban and a rural sub-county in Wakiso district to determine the prevalence and risk factors for cardiovascular disease \[[@CR15]\]. The detailed methods of the MEPI-CVD survey have been described elsewhere \[[@CR15], [@CR16]\]. All the sub-counties in Wakiso district were stratified into rural and urban and then one sub-county was chosen from each stratum by simple random sampling. One urban sub-County (Nansana Town Council) was randomly selected out of 5 urban sub-counties and one rural sub-County (Busukuma) was randomly selected out of 13 rural sub-counties in Wakiso district (see Fig. [1](#Fig1){ref-type="fig"}. Study Area: Map showing rural area of Busukuma and periurban area of Nansana, Wakiso District, Uganda. Caption: This image was modified from Wikimedia Commons for maps by Dr. Robert Kalyesubula). All households and other key features in the selected sub-counties were mapped and enumerated to generate a sampling frame for the survey. Household locations were mapped using hand-held global positioning system (GPS) receivers. A total of 5,420 households was selected to participate in the survey using a list randomly generated from the household enumeration database. In each of the selected households, one adult (18 years or older) was selected to participate in the survey. Households without an adult were excluded leaving a total of 4,952 participants in the study. Following informed consent, a structured standard questionnaire adopted from WHO STEPS was administered to the household respondents. The questionnaire was administered through face-to-face personal interviews in a research clinic, ensuring a setting that provided maximum privacy to conduct the interview. The data collected included: demographics (age, sex, and address), diet, tobacco and alcohol consumption and medical history, as well as smoke exposure, socio-economic status and family history of NCDs. The researchers also undertook physical measurements for blood pressure, height, weight to obtain the BMI, waist circumference and hip circumference to obtain the waist-hip ratio following standard protocols. Blood samples were obtained via venous phlebotomy for investigations including; HIV, fasting blood sugar and full blood counts. Urine analysis was done using a dipstick. All participants from the primary MEPI-CVD linked study with complete data including urine protein were eligible for the CKD study.Fig. 1Map of Uganda Showing urban and rural areas from Wakiso district. This map was adopted and modified by Dr Robert Kalyesubula from wikimedia

During the MEPI-CVD survey, blood samples were stored as plain serum in microvials in a negative 80 °C freezer at the MBN Clinical Laboratory in Kampala, Uganda. The MBN Clinical laboratory is an internationally accredited laboratory with quality standards for both real time and retrospective specimen analysis. We retrieved the stored samples for the randomly selected 1000 participants who met the inclusion criteria and tested their creatinine levels using the Cobas Auto Analyzer (Roche Diagnostics, North America) with a standard reference range of; 66 -106umol/L. Of the 1000 participants 955 had complete samples. The creatinine level measured for each of the participants was used to estimate the glomerular filtration rate using the Cockcroft-Gault formula adjusted for BMI in accordance with previous studies performed in Uganda \[[@CR6]\].

Statistical analysis {#Sec3}
--------------------

To determine the prevalence of kidney disease, we used the proportion of patients with proteinuria of \> 1+ with an estimated glomerular filtration rate of less than 90mls/min/1.73 m^2^ and divided this by the total number of patients recruited in the study. Proteinuria was graded as: negative (less than 10 mg per dL), trace (10 to 20 mg per dL), 1+ (30 mg per dL), 2+ (100 mg per dL), 3+ (300 mg per dL) or 4+ (1,000 mg per dL) \[[@CR17]\]. Chronic kidney disease was further staged according severity based on the National Kidney Foundation guidelines \[[@CR18]\]. We defined kidney disease as a creatinine clearance of less than 90mls/min/1.73 m2 and chronic kidney disease as a creatinine clearance of less than 60mls/min/1.73 m2. Z-scores were generated to compare the proportions at each severity level using the CKD-Epi values as reference \[[@CR19]\]. The four categories of the Socio-economic Score (SES) were derived from conducting Principle Component Analysis (PCA) on a statistical software using variables relating to household infrastructure and property ownership. Logistic regression was used to identify factors associated with having kidney disease and odds ratios with their 95% confidence intervals as the measures of association. We adhered to the STROBE guidelines/methodology for reporting our findings.

Ethics {#Sec4}
------

Ethical approval was obtained from Makerere University School of Medicine Research and Ethics Committee as well as the Uganda National Council for Science and Technology (UNCST). Patients provided informed consent for the parent study (MEPI-CVD study) and future use of the samples which were stored. Administrative permission to use the stored samples was also obtained from the Principal Investigator of the MEPI-CVD study.

Results {#Sec5}
=======

Characteristics of participants {#Sec6}
-------------------------------

Of 1000 patients screened from the MEPI-CVD study, 955 (96%) had complete data to determine the prevalence and associated factors for CKD. The remaining 45 participants had incomplete samples for measurement of creatinine but did not differ significantly from those included in the study. We additionally compared the demographics of the 955 participants included for the CKD study with the 3,997 excluded from the original study and found no differences in demographic variables.

Of the 955 participants, the majority (67%, *n* = 640) were female and more than two-thirds (73%, *n* = 696) were peri-urban residents. The median age of the participants was 31 years (IQR, 24--42). A total of 93 (9.7%) participants were HIV-infected, while one in four (25%, *n* = 239) were hypertensive-defined as being on drugs for hypertension or having a systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg at three consecutive measurements. The majority of participants had never smoked (90%, *n* = 862) nor used alcohol (88%, *n* = 841). A summary of selected characteristics of the participants by gender is presented in Table [1](#Tab1){ref-type="table"}. The rural and peri-urban communities significantly differed on all demographic factors except HIV- infection status and presence of proteinuria. Participants from peri-urban communities were more likely to be younger, poorer, and normotensive with higher BMI (see Table [2](#Tab2){ref-type="table"}).Table 1Baseline characteristics of study participants from Wakiso, Uganda by genderCharacteristicTotal *N* = 955Males (*N* = 315)Female (*N* = 640)Median age (IQR)31 (24--42)30 (24--40)32 (25--43)Age group 18--29410 (42.9)151 (47.9)259 (40.5) 30--39261 (27.3)78 (24.8)183 (28.6) 40--49136 (14.2)48 (15.2)88 (13.7) 50--5973 (7.6)17 (5.4)56 (8.8) 60+75 (7.9)21 (6.7)54 (8.4)Sub-county Nansana Town Council696 (72.9)213 (67.6)483 (75.5) Busukuma259 (27.1)102 (32.4)157 (24.5)SES^a^ Poorest226 (23.7)75 (23.8)151 (23.6) Poor225 (23.6)85 (26.9)140 (21.9) Less poor261 (27.3)80 (25.4)181 (28.3) Least poor243 (25.4)75 (23.8)168 (26.2)Median Weight (IQR)61 (53--71)61 (56--69)60 (52--72)BMI groups Underweight52 (5.5)24 (7.6)28 (4.4) Normal544 (56.9)230 (73.0)314 (49.1) Overweight231 (24.2)49 (15.6)182 (28.4) Obese128 (13.4)12 (3.8)116 (18.1)HIV-Infection No862 (90.3)289 (91.8)573 (89.5) Yes93 (9.7)26 (8.2)67 (10.5)Diabetic n (%) Normal733 (76.8)271 (86.0)462 (72.2) Impaired tolerance173 (18.1)38 (12.1)135 (21.1) Diabetic49 (5.1)6 (1.9)43 (6.7)Hypertension n (%) Normal716 (75.0)235 (74.6)481 (75.2) Hypertensive239 (25.0)80 (25.4)159 (24.8)Smoking, n (%) Never smoked862 (90.3)259 (82.2)603 (94.2) Previously smoker39 (4.1)17 (5.4)22 (3.4)Current smoker54 (5.6)39 (12.4)15 (2.3)Alcohol use n (%) None841 (88.1)254 (80.6)587 (91.7) Mild33 (3.5)16 (5.1)17 (2.6) Moderate52 (5.4)25 (7.9)27 (4.2) Heavy29 (3.0)20 (6.4)9 (1.4)Mean serum creatinine (SD)0.66 (0.18)0.75 (0.2)0.62 (0.2)CCr (mls/min/1.73 m2)median (IQR) CG124 (101--158)124 (103--157)124 (101--160) MDRD140 (116--177)149 (123--188)136 (112--170) CKD-Epi138 (122--152)141 (128--155)136 (119--150)Proteinuria (urine protein ≥ 1+) No952 (99.7)314 (99.7)638 (99.7) Yes3 (0.3)1 (0.3)2 (0.3)*Abbreviations: BMI* Body mass index*, CG* Cockroft Gault*, CCr* creatinine clearance*, CKD-EPI* Chronic Kidney Disease Epidemiology Consortium equation*, IQR* Interquartile range*, MDRD 4-*variable Modification of Diet in Renal Disease equation*,* SES social economic score^a^Socio-economic Score (SES) derived from conducting Principle Component Analysis (PCA) on a statistical software using variables relating to household infrastructure and property ownership Table 2Baseline characteristics of study participants from Wakiso, Uganda by sub-countyCharacteristicNansana (*N* = 696)Busukuma (*N* = 259)*p*-valueMedian age (IQR)30 (24--38)38 (27--50)\<0.001Age group 18--29335 (48.1)75 (28.9)\<0.001 30--39202 (29.0)59 (22.8)0.056 40--4980 (11.5)56 (21.6)\<0.001 50--5944 (6.3)29 (11.2)\<0.011 60+35 (5.0)40 (15.4)\<0.001Sex Male213 (30.6)102 (39.4)\<0.001 Female483 (69.4)157 (60.6)SES Poorest205 (29.4)21 (8.1)\<0.001 Poor192 (27.6)33 (12.8)\<0.001 Less poor126 (18.1)135 (52.1)\<0.001 Least poor173 (24.9)70 (27.0)0.508Median Weight (IQR)62 (55--72)58 (50--66)\<0.001BMI groups Underweight31 (4.5)21 (8.1)0.029 Normal365 (52.4)179 (69.1)\<0.001 Overweight186 (26.7)45 (17.4)0.003 Obese114 (16.4)14 (5.4)\<0.001HIV-Infection No622 (89.4)240 (92.7)0.126 Yes74 (10.6)19 (7.3)Diabetic n (%) Normal516 (74.2)217 (83.8)0.002 Impaired tolerance139 (19.9)34 (13.1)0.015 Diabetic41 (5.9)8 (3.1)0.082Hypertension n (%) Normal535 (76.9)181 (69.9)0.026 Hypertensive161 (23.1)78 (30.1)Smoking, n (%) Never smoked631 (90.7)231 (89.2)\<0.001 Previously smoker31 (4.4)8 (3.1)0.365 Current smoker34 (4.9)20 (7.7)0.096Alcohol use n (%) None622 (89.4)219 (84.6)0.042 Mild23 (3.3)10 (3.9)0.652 Moderate31 (4.5)21 (8.1)0.029 Heavy20 (2.9)9 (3.5)0.632Mean serum creatinine (SD)0.65 (0.54--0.76)0.67 (0.53--0.81)0.297 CG130 (87.7--161.5)112 (88.9--142.5)\<0.001 MDRD141 (117.4--177.5)139 (108.5--174.7)0.859 CKD-Epi139 (125.1--153.1)132 (114.9--147.1)\<0.001Proteinuria (urine protein ≥ 1+) No693 (99.6)2590.308 Yes3 (0.4)0Socio-economic Score (SES) derived from conducting Principle Component Analysis (PCA) on a statistical software using variables relating to household infrastructure and property ownership*Abbreviations: BMI* Body mass index, *CG* Cockroft Gault, *CCr* creatinine clearance, *CKD-EPI* Chronic Kidney Disease Epidemiology Consortium equation, *IQR* Interquartile range, *MDRD* 4-variable Modification of Diet in Renal Disease equation, *SES* social economic score

Prevalence of kidney disease {#Sec7}
----------------------------

The prevalence of kidney disease in this study population was 15.2% (*n* = 145) using the Cockcroft Gault formula. The prevalence according to CKD stages were; CKD stage 1 in 6.2% (*n* = 59), stage 2 in 12.7% (*n* = 121), stage 3 in 2.4% (*n* = 23), stage 4 in 0% (*n* = 0) and stage 5 (end stage kidney disease) in 0.1% (*n* = 1). A total of 6.2% (59) participants had normal glomerular filtration rates but with urinary abnormalities. More than a fifth (21.4%, *n* = 204) of the participants had renal abnormalities of creatinine and urinalysis detected (see Fig. [2](#Fig2){ref-type="fig"}). Of those with urine abnormalities 3 (0.3%) had proteinuria and 55 (5.6%) participants had hematuria.Fig. 2Prevalence of kidney disease by stage

Comparison of the prevalence of stages of CKD using the different formulae for estimation of glomerular filtration rate {#Sec8}
-----------------------------------------------------------------------------------------------------------------------

Sensitivity analysis was done using different formulae. The average glomerular filtration rates did not differ (see Table [3](#Tab3){ref-type="table"}). Using the three internationally recognized estimated glomerular filtration rate (eGFR) formulae namely: Chronic Kidney Disease -Epidemiology Consortium equation(CKD-Epi), Modification of Diet in Renal Disease (MDRD) and the Cockcroft Gault (CG); more than a fifth of participants had kidney abnormalities. The prevalence for stage 1 kidney disease was similar using the three formulae. Significant differences in prevalence were noted for stage 2 kidney disease with CKD-Epi detecting 2.9% (*n* = 28), CG at 12.7% (*n* = 121) and MDRD showing 5.9% (*n* = 57) (*p* \< 0.001). For advanced kidney disease stage 4 and 5; there were no patients with CKD identified by the CKD-Epi or MDRD formulae but one patient (0.1%) was identified to have ESRD with the CG formula (see Table [4](#Tab4){ref-type="table"}).Table 3Glumerular filtration rates by different formulaseGFRMedian, IQR (males)Median, IQR (Females)Median, IQR (Overall)eGFR-CG124.1 (102.6--157.2)123.6 (101.1--159.5)123.9 (101.4--158.0)eGF- MDRD148.9 (122.6--187.9)135.6 (111.7--170.1)140.5 (115.8--176.6)eGFR- CKD-Epi140.8 (127.5--155.0)135.8 (119.4--149.6)137.6 (121.9--152.1)*eGFR* estimated glomerular filtration rate, all measurements in mls/min/1.73 m2, *CG* Cockroft Gault, *MDRD* 4-variable Modification of Diet in Renal Disease equation, *CKD-EPI* Chronic Kidney Disease Epidemiology Consortium equation Table 4Chronic Kidney Disease stages according to the National Kidney Foundation, using Cockroft Gault and Modification of Diet in Renal Disease Glomerular Filtration Rate estimations compared with CKD-EpiGFR estimationCKD-Epi *n* (%)\
*N* = 955CG est *n* (%)\
*N* = 955p (CG vs CKD --Epi)MDRD n (%)p (MDRD vs CKD --Epi)0≥90, without urine dipstick abnormality861 (90.2)751 (78.6)\<0.0001834 (87.3)0.0451≥ 90, with urine dipstick abnormality64 (6.7)59 (6.2)0.65662 (6.5)0.860260--89, with urine dipstick abnormality28 (2.9)121 (12.7)\<0.000157 (5.9)0.0013a45--59.9, with or without urine dipstick abnormality1 (0.1)15 (1.6)0.00041 (0.1)1.0003b30--44.9, with or without urine dipstick abnormality1 (0.1)8 (0.8)0.0221 (0.1)1.000415--29.9, with or without urine dipstick abnormality001.00001.0005\< 15, with or without urine dipstick abnormality01 (0.1)0.32801.000*Abbreviations: CG* Cockroft Gault*, CKD-Epi* Chronic Kidney Disease Epidemiology Consortium equation*, e-GFR* estimated glomerular filtration rate*, MDRD* 4-variable Modification of Diet in Renal Disease equation

Risk factors for kidney disease {#Sec9}
-------------------------------

Being female OR 1.8 (95% CI 1.2--2.8), age over 30 years OR 2.2 (95% CI 1.2--3.8) and a high social economic status (least poor) OR 2.1 (95% CI 1.3--3.6) were associated with kidney disease. The odds for age increased exponentially for higher age groups. Body mass index (BMI) above 25 Kg/m^2^ was protective against CKD OR 0.1 (95% CI 0.04--0.2).

On bivariate analysis, participants from rural Busukuma were three times OR 3.2 (95% CI 2.2--4.5) more likely to have kidney disease compared to their peri-urban counterparts from Nansana. However, this association diminished on adjusting for confounders including age and social economic status. Similarly, on bivariate analysis, participants with hypertension were 2 times more likely to have kidney disease but this was largely confounded by age and body mass index (see Table [5](#Tab5){ref-type="table"}). The traditional risk factors of HIV-infection, diabetes mellitus, smoking and alcohol intake were not significantly associated with kidney disease in this study (see Table [5](#Tab5){ref-type="table"}).Table 5Association between kidney disease (Cockcroft-Gault formula) and different predictor variablesCharacteristicn/N (%)Unadjusted OR (95% CI)*p*-valueAdjusted OR (95% CI)*p*-valueSub-county Nansana74/696 (10.6)11 Busukuma71/259 (27.4)3.2 (2.2--4.5)\<0.0011.5 (0.99--2.4)0.053Sex Male41/315 (13.0)11 Female104/640 (16.2)1.3 (0.2--1.9)0.1911.8 (1.2--2.8)0.010Age group 18--2928/410 (6.8)11 30--3927/261 (10.3)1.6 (0.9--2.7)0.1082.2 (1.2--3.8)0.009 40--4932/136 (23.5)4.2 (2.4--7.3)\<0.0014.3 (1.2--3.8)\<0.001 50--5917/73 (23.3)4.1 (2.1--8.1)\<0.0015.5 (2.4--7.8)\<0.001 60+41/75 (54.7)16.5 (9.1--29.8)\<0.00117 (8.4--35.4)\<0.001SES Poorest25/226 (11.1)1 Poor21/225 (9.3)0.8 (0.4--1.5)0.545 Less poor55/261 (21.1)2.1 (1.3--3.6)0.003 Least poor44/243 (18.1)1.8 (1.1--3.0)0.033BMI groups Underweight21/52 (40.4)11 Normal105/544 (19.3)0.3 (0.2--0.6)0.0010.4 (0.2--0.8)0.008 Overweight18/231 (7.8)0.1 (0.05--0.3)\<0.0010.1 (0.04--0.2)\<0.001 Obese1/128 (0.8)0.01 (0.002--0.09)\<0.0010.01 (0.001--0.1)\<0.001HIV-Infection No130/862 (15.1)1 Yes15/93 (16.1)1.1 (0.6--1.9)0.789Diabetic Normal106/733 (14.5)11 Impaired tolerance29/173 (16.8)1.2 (0.8--1.9)0.4451.2 (0.7--2.0)0.544 Diabetic10/49 (20.4)1.5 (0.7--3.1)0.2602.4 (0.98--5.8)0.055Hypertension Normal92/716 (12.9)11 Hypertensive53/239 (22.2)1.9 (1.3--2.8)0.0011.2 (0.7--1.9)0.474Smoking Never smoked133/862 (15.4)1 Previously smoker3/39 (7.7)0.5 (0.1--1.5)0.198 Current smoker9/54 (16.7)1.1 (0.5--2.3)0.808Alcohol use None132/841 (15.7)1 Mild2/33 (6.1)0.3 (0.1--1.5)0.150 Moderate8/52 (15.4)0.9 (0.4--2.1)0.952 Heavy3/29 (10.3)0.6 (0.2--2.1)0.438Age-group confounds HT, BMI confounds HT

We also run an analysis using the CKD-Epi and MDRD for CKD associated factors (data not shown). Female sex, age above 30 years, and socio-economic status were found to be associated with CKD using the MDRD and CG formulae. Age above 30 years and hypertension were found to be associated with CKD using the CKD-Epi formula. Diabetes mellitus was not consistently identified as a risk factor for kidney disease with MDRD identifying it as a significant factor while CG and CKD-Epi did not.

Discussion {#Sec10}
==========

We found a high prevalence of kidney disease at 15.2%, CKD of 2.5% with ESRD in 0.1% in Wakiso district, Uganda. The high prevalence of kidney disease in rural and peri-urban areas highlights the current burden of NCDs. High prevalence of kidney disease has been identified in other areas of SSA; in Tanzania the prevalence of CKD was found to be 7.0% overall with 15.2% in the urban population while a systematic review estimates an overall prevalence of CKD in SSA at 13.9% \[[@CR2], [@CR10]\]. These findings have far reaching consequences to a developing country of 34.9 million people \[[@CR20]\] with few trained specialist and few dialysis centres to support the increased burden of kidney disease \[[@CR21]\]. The cost of caring for patients with ESRD is extremely high. Hemodialysis which is one of the available means for management of ESRD in SSA has been estimated to cost between 7,000 and 55,000 US dollars per patient per year depending on whether the facility is private or government supported \[[@CR21]--[@CR23]\]. For a perspective, the average household (average of 5 persons) monthly income for Ugandans is estimated at a meager 78 US dollars per month with an average monthly expenditure of 12 US dollars on healthcare \[[@CR24], [@CR25]\].

There was a significant difference in the prevalence and stages of chronic kidney disease when different formulae were used to estimate the glomerular filtration rate. Similar findings have been noted in other studies. A study by Wyatt \[[@CR26]\] found that CG over estimates the rate of CKD while Kaze noted different rates of CKD ranging from 4.4 to 8.8% depending on which formula was used \[[@CR27]\]. The CKD-Epi has been found to be more accurate in patients with near normal kidney function \[[@CR28]\]. However, highest correlation in clinical practice was found with CG when corrected for low body mass \[[@CR29]\]. The equations used to determine the estimated glomerular filtration rate (eGFR) have not been validated among populations in SSA \[[@CR30], [@CR31]\]. Thus, it is still difficult to determine the optimal eGFR formula to use in establishing the prevalence and risk factors for CKD particularly in resource-limited settings. Variability in formulae for diagnosing CKD has far reaching implications as patients may be misclassified and given the wrong diagnostic stage which may lead to anxiety and unnecessary treatments if the diagnostic stage is worse than the true GFR. Conversely, patients may miss treatment if they are given a more favourable diagnostic stage than their true GFR. It is therefore critical that a true GFR is determined for each patient. Resolving this issue will require larger population-based studies in SSA to determine the true GFR formula for this region.

Age (above thirty years), female gender, and high social economic status were associated with increased risk of kidney disease. This has been found by other studies from Africa \[[@CR2], [@CR27]\]. In contrast, low socioeconomic status has been associated with both development and progression of CKD in Europe and United States of America \[[@CR25], [@CR32]\]. This may be attributed to environmental and lifestyle factors which differ across the different regions \[[@CR33]\]. In general, the prevalence of CKD is greater among women than in men across all ages from both developed countries and SSA \[[@CR34]\]. The difference in CKD prevalence between males and females could be explained by the fact that women have less muscle mass and there are differences in the glomerular structure and hormone metabolism which may play a role in this gender disparity \[[@CR35]\]. We did not find a significant difference in prevalence between peri-urban Nansana Town Council and rural Busukuma. This is in contrast to the study in neighbouring Tanzania where rural communities had a low prevalence at 2.0% compared with the urban in 15.7% \[[@CR10]\]. The complicated association between age, poverty and BMI in urban and rural areas may have had an impact on the results between these two communities.

Diabetes mellitus, smoking and alcohol intake were not key factors associated with kidney disease in this study population, contrary to previous findings. This may be due the fact that the majority of participants did not report use of alcohol or smoking. In a recently completed national survey for diabetes in Uganda, only 1.4% (95% CI 0.9--1.9%, *N* = 3689) participants had diabetes mellitus \[[@CR36]\]. The low prevalence of these well known risk factors for CKD in our participants makes any comment of their impact difficult to ascertain. In a study by Stanifer et al., half of the cases of CKD (49.1%) were not associated with any of the measured risk factors of hypertension, diabetes, or HIV-infection \[[@CR10]\]. In developed countries and worldwide, the majority of kidney disease is due to diabetes mellitus followed by hypertension \[[@CR37]\]. It is thus still unclear as to what may be driving the high levels of kidney disease in the rural and semi-urban areas of SSA. Future research needs to look into the peculiar drivers of CKD in SSA. Hypertension and diabetes mellitus can easily be diagnosed even at the lower facility levels. But if there are other unknown causes such as glomerular (especially post-infectious) and interstitial renal diseases driving the epidemic of kidney disease in Uganda, these need to be urgently identified so that appropriate steps to prevent progression to end-stage renal disease can be effected. Treatment of ESRD is not clinically and economically feasible for most low- and middle-income countries \[[@CR38]\].

Our study had several strengths. This was a large community based survey, an attribute that is likely to give a proxy estimate of the burden of kidney disease in Uganda. In addition, our study population was both rural and semi-urban and therefore in a true epidemiological transition. The results of our study can therefore be generalized to many populations on the African continent that are in a similar transition. We also compared the three e-GFR estimation methods and highlighted the significant differences that exist between them which may have far reaching consequences to patient care.

However, our study also had a few limitations. The primary study was a survey, cross sectional in nature and some data on key parameters for establishing chronic kidney disease like the abdominal ultrasound scan were missing. We used proteinuria as a surrogate marker well aware that it may be affected by other causes like urinary tract infections among others. Furthermore, proteinuria rather than microalbuminuria was used for this study. In addition, we were also not able to determine whether the kidney dysfunction was acute or chronic because we did not have repeat (\>3 month) creatinine. Nevertheless, we believe that this study will create awareness on the magnitude of kidney disease in Uganda and hopefully stimulate further research into the underlying etiology and set in motion ways to prevent it.

Conclusion {#Sec11}
==========

We found a high prevalence of kidney disease in Uganda which could not be explained by the traditional causes of CKD and noted significant levels of disagreement in the formulae used to estimate glomerular filtration rates. Further studies are needed to characterize the drivers of kidney disease beyond diabetes and hypertension as the prevalence of these diseases continues to rise.
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